Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles
Advanced Functional Materials · 2024-02 · 34 (8)
DOI: 10.1002/adfm.202308446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 20.11.2023. Verfasst von Lin Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma, 73019, USA. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 283 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, University of Oklahoma.
Abstract (Originalsprache)
Most nanomedicines require efficient in vivo delivery to elicit meaningful diagnostic and therapeutic effects. However, en route to their intended tissues, systemically administered nanoparticles often encounter delivery barriers. To describe these barriers, the term “nanoparticle blood removal pathways” (NBRP) is proposed, which summarizes the interactions between nanoparticles and the body's various cell‐dependent and cell‐independent blood clearance mechanisms. Nanoparticle design and biological modulation strategies are reviewed to mitigate nanoparticle‐NBRP interactions. As these interactions affect nanoparticle delivery, the preclinical literature from 2011–2021 is studied, and the nanoparticle blood circulation and organ biodistribution data are analyzed. The findings reveal that nanoparticle surface chemistry affects the in vivo behavior more than other nanoparticle design parameters. Combinatory biological‐PEG surface modification improves the blood area under the curve by ≈418%, with a decrease in liver accumulation of up to 47%. A greater understanding of nanoparticle‐NBRP interactions and associated delivery trends will provide new nanoparticle design and biological modulation strategies for safer, more effective, and more efficient nanomedicines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, Oklahoma, 73019, USA.
- College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73117, USA.
- Department of Biostatistics and Epidemiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73012, USA.
- Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, USA.
- Institute for Biomedical Engineering, Science, and Technology (IBEST), Norman, Oklahoma, 73019, USA.
ORCID-Profile: Stefan Wilhelm
Förderung
- NIGMS NIH HHS
- University of Oklahoma
Zitieren
APA
Wang, L., Quine, S., Frickenstein, A. N., Lee, M., Yang, W., Sheth, V. M., Bourlon, M. D., He, Y., Lyu, S., Garcia-Contreras, L., Zhao, Y. D., & Wilhelm, S. (2024). Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles. Advanced Functional Materials, 34(8). https://doi.org/10.1002/adfm.202308446
Vancouver
Wang L, Quine S, Frickenstein AN, Lee M, Yang W, Sheth VM, et al. Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles. Advanced Functional Materials. 2024;34(8). doi:10.1002/adfm.202308446
BibTeX
@article{Wang2024,
author = {Wang, Lin and Quine, Skyler and Frickenstein, Alex N and Lee, Michael and Yang, Wen and Sheth, Vinit M and Bourlon, Margaret D and He, Yuxin and Lyu, Shanxin and Garcia-Contreras, Lucila and Zhao, Yan D and Wilhelm, Stefan},
title = {Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles},
journal = {Advanced Functional Materials},
year = {2024},
volume = {34},
number = {8},
doi = {10.1002/adfm.202308446}
}
EUVIMED